Loading clinical trials...

Stereotactic Body Radiation Therapy Versus Radiofrequency Ablation for Small Renal Masses | Clinical Trials | Clareo Health

UNKNOWNNA

Stereotactic Body Radiation Therapy Versus Radiofrequency Ablation for Small Renal Masses

A Prospective Randomized Pilot Trial of Stereotactive Body Radiation Therapy Versus Radiofrequency Ablation for the Management of Small Renal Masses.

NCT03811665•St. Joseph's Healthcare Hamilton

View on ClinicalTrials.gov

Summary

The execution of this study is pertinent to evaluating SBRT's short- and long-term efficacy and safety in the treatment of SRMs. This study will be the first to compare RFA and SBRT in the treatment of SRMs.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patients ≥18 years of age and capable of providing informed consent
•Patients scheduled for treatment of their SRM using SBRT or RFA
•Patients who received a biopsy of their SRM prior to their scheduled SBRT or RFA treatment
•Patients who are willing to have a biopsy 12 months post-procedure
•Patients with renal tumor(s) ≤ 4.0 cm

Exclusion Criteria

•Patients with large renal tumor(s)\>4.0 cm
•Patients who are unable to have a general anesthetic
•Patients who did not receive a biopsy of their SRM prior to their scheduled SBRT or RFA treatment
•Patients who are unable to comply with post-operative and/or follow-up protocol/phase of study
•Evidence of metastatic disease
•Uncorrectable bleeding diathesis

Locations (1)

McMaster Institute of Urology - St. Joseph's Healthcare Hamilton

Hamilton, Ontario, Canada

Key Dates

Start Date

October 1, 2019

Primary Completion Date

June 30, 2022

Completion Date

December 30, 2022

Last Updated

December 16, 2021

Enrollment

ESTIMATED participants

Conditions

Small Renal Masses (SRM)

Interventions

Radiofrequency Ablation

PROCEDURE

Stereotactive body radiation therapy

RADIATION